Consensus Laboratorios Farmaceuticos Rovi, S.A.

Equities

Market Closed - BME Other stock markets 11:41:06 2024-05-02 EDT			5-day change	1st Jan Change
82.2 ^EUR	-2.49%		+2.18%	+36.54%

04-02	Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment	MT
03-12	Rovi, Partners to Form Entity for Advanced Therapies R&D	MT

03320.pOGmSwlqOhlHcTSl0N4zC3Cgt1Jy-oxFNJjkc0xYM30.6qr8BThHCn0kOHrLk5ZROiHE3ysdrtwCWv-HHhQafA-Ju8oAWQRLYT88DA~4a5d65996432bd642d7619551f570287

22-02-23

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

82.2 EUR

Average target price

85.12 EUR

Spread / Average Target

+3.56%

High Price Target

100 EUR

Spread / Highest target

+21.65%

Low Price Target

66 EUR

Spread / Lowest Target

-19.71%

Trading Rating

Investor Rating

ESG Refinitiv

B+